Co2lift® Announces Advancements In Carboxytherapy With Patented Technology And Clinical Validation
(MENAFN- EIN Presswire)
In a market where many CO2-based gels and packs rely on fast reactions lasting only minutes, CO2Lift® introduces a patented lactone hydrolysis system that steadily releases CO2 for more than an hour. This sustained delivery method is designed to allow deeper absorption into the skin.
“Our patented system ensures controlled and consistent CO2 delivery,” said Lana Kerr, Founder & CEO of Lumisque Skincare.“It's a technology that reflects years of development and testing, and it is now being integrated by physicians into both medical and aesthetic settings.”
Technology and Clinical Research
- Patented Technology: Patent JP6080810B2 utilizes a lactone hydrolysis mechanism that forms a solidifying gel, helping optimize gas absorption.
- Clinical Evidence: Backed by IRB-approved clinical trials and peer-reviewed publications, CO2Lift® has been studied for applications including wound healing, barrier repair, and dermal regeneration. Documented outcomes include accelerated closure of diabetic ulcers and improvements in circulation compared with other formulations.
- Medical-Grade Safety: Unlike cosmetic-grade CO2 products marketed online, CO2Lift® has been developed with safety standards suitable for use on compromised skin and in post-procedure care.
A Category in Transition
Carboxytherapy-the therapeutic use of CO2 to stimulate circulation and tissue repair-has gained significant interest worldwide. However, experts note that the category is fragmented, with many consumer products marketed for short-term cosmetic effects rather than therapeutic outcomes.
“Education matters because when skin is compromised-whether from surgery, chronic conditions, or aging-the treatment must be proven and safe,” added Kerr.“Our mission has always been to bring clarity and elevate standards in this space.”
About CO2Lift®
CO2Lift® by Lumisque Skincare is a professional-grade carboxytherapy treatment distributed in the United States. Powered by patented technology and validated through clinical research, CO2Lift® is used by physicians and practitioners to support non-invasive skin regeneration.
New system introduces sustained CO2 delivery, supported by peer-reviewed research and physician adoption in medical and aesthetic care
MIAMI, FL, UNITED STATES, August 28, 2025 /EINPresswire / -- Lumisque Skincare today announced new developments in carboxytherapy with its CO2Lift® treatment, designed to bring clarity and higher safety standards to a rapidly growing aesthetics category.In a market where many CO2-based gels and packs rely on fast reactions lasting only minutes, CO2Lift® introduces a patented lactone hydrolysis system that steadily releases CO2 for more than an hour. This sustained delivery method is designed to allow deeper absorption into the skin.
“Our patented system ensures controlled and consistent CO2 delivery,” said Lana Kerr, Founder & CEO of Lumisque Skincare.“It's a technology that reflects years of development and testing, and it is now being integrated by physicians into both medical and aesthetic settings.”
Technology and Clinical Research
- Patented Technology: Patent JP6080810B2 utilizes a lactone hydrolysis mechanism that forms a solidifying gel, helping optimize gas absorption.
- Clinical Evidence: Backed by IRB-approved clinical trials and peer-reviewed publications, CO2Lift® has been studied for applications including wound healing, barrier repair, and dermal regeneration. Documented outcomes include accelerated closure of diabetic ulcers and improvements in circulation compared with other formulations.
- Medical-Grade Safety: Unlike cosmetic-grade CO2 products marketed online, CO2Lift® has been developed with safety standards suitable for use on compromised skin and in post-procedure care.
A Category in Transition
Carboxytherapy-the therapeutic use of CO2 to stimulate circulation and tissue repair-has gained significant interest worldwide. However, experts note that the category is fragmented, with many consumer products marketed for short-term cosmetic effects rather than therapeutic outcomes.
“Education matters because when skin is compromised-whether from surgery, chronic conditions, or aging-the treatment must be proven and safe,” added Kerr.“Our mission has always been to bring clarity and elevate standards in this space.”
About CO2Lift®
CO2Lift® by Lumisque Skincare is a professional-grade carboxytherapy treatment distributed in the United States. Powered by patented technology and validated through clinical research, CO2Lift® is used by physicians and practitioners to support non-invasive skin regeneration.
Jessica Kopach
The JKO Agency
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
- United States Lubricants Market Growth Opportunities & Share Dynamics 20252033
- UK Digital Health Market To Reach USD 37.6 Billion By 2033
- Immigration Consultancy Business Plan 2025: What You Need To Get Started
- United States Animal Health Market Size, Industry Trends, Share, Growth And Report 2025-2033
- Latin America Mobile Payment Market To Hit USD 1,688.0 Billion By 2033
- United States Jewelry Market Forecast On Growth & Demand Drivers 20252033
More Story
Comments
No comment